AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32283100.
- Also identified by DOI 10.1053/j.gastro.2020.04.012 and PMC identifier 7151253.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Gastroenterology
- Inflammatory Bowel Diseases
- Pandemics
- Pneumonia, Viral
- Practice Guidelines as Topic